Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Lipitor and lactose intolerance?Why did bc delist xeljanz?How does antacid timing affect lipitor's efficacy?Xeljanz patent expiry in australia?Synthon pharms inc palbociclib?
See the DrugPatentWatch profile for lanreotide
The initial regulatory approval date for lanreotide from Ipsen is not provided in the available information I have access to.
“Lanreotide (Ipsen)” can refer to different specific presentations/brands depending on the country and whether you mean: - EU first approval (European Medicines Agency, EMA) - US first approval (FDA) - a particular formulation (e.g., depot dosing strengths) If you tell me the exact brand/presentation and the region (EU or US), I can pinpoint the correct initial approval date using the relevant regulatory record.
Other Questions About Lanreotide :